Wilmer Cutler Pickering Hale and Dorr and Ice Miller have advised Schrödinger. Schrödinger, Inc. has announced the formation of Tectora Therapeutics, a newly established biotechnology company,...
Schrödinger Forms Tectora Therapeutics and Secures $55 Million Series A Investment
Ratio Therapeutics Raises $70 Million in Series C Funding
Wilmer Cutler Pickering Hale and Dorr has advised Ratio Therapeutics. Ratio Therapeutics, Inc., a clinical-stage pharmaceutical company focused on radiopharmaceuticals for cancer treatment, has announced the...
Q32 Bio Announces $200 Million Public Offering of Shares and Pre-Funded Warrants
Goodwin Procter LLP and McCarter & English LLP have advised Q32 Bio Inc. Wilmer Cutler Pickering Hale and Dorr LLP has advised the underwriters. Q32 Bio...
PTC Therapeutics Raises $550 Million in Convertible Notes Offering
Wilmer Cutler Pickering Hale and Dorr has advised PTC Therapeutics, Inc. Davis Polk advised the representative of several initial purchasers. PTC Therapeutics, Inc., a publicly-traded global...
Q32 Bio Raises $55 Million in Private Placement
Goodwin Procter LLP has advised Q32 Bio Inc. WilmerHale has advised the placement agents. Q32 Bio Inc. (Nasdaq: QTTB), a clinical stage biotechnology company, has completed...
Celldex Therapeutics Raises $345 Million in Public Offering of Common Stock
Lowenstein Sandler LLP has advised Celldex Therapeutics, Inc., and Wilmer Cutler Pickering Hale and Dorr has represented the underwriters. Celldex Therapeutics, Inc. (Nasdaq: CLDX) has announced...
Solid Biosciences Secures $240 Million in Private Placement
Wilmer Cutler Pickering Hale and Dorr has advised Solid Biosciences. Solid Biosciences Inc. (NASDAQ: SLDB) has announced that it has entered into a securities purchase agreement...
PAQ Therapeutics Closes Series B Extension, Totaling $77 Million to Advance KRAS Degrader Therapies
WilmerHale has advised PAQ Therapeutics. PAQ Therapeutics, a clinical-stage oncology biotechnology company, has announced the closing of a Series B extension that brings the company’s total...
Day One Biopharmaceuticals to Acquire Mersana Therapeutics in Transaction Valued Up to $285 Million
Wilmer Cutler Pickering Hale and Dorr has advised Mersana Therapeutics. Fenwick & West has advised Day One Biopharmaceuticals. Wilson Sonsini Goodrich & Rosati advised Day One...
Access Industries Completes Secondary Offering of Disc Medicine Shares
Debevoise & Plimpton LLP has advised Access Industries. Goodwin Procter LLP and White & Case LLP, along with Wolf, Greenfield & Sacks, P.C., have advised Disc...
Xilio Therapeutics Closes $50 Million Public Offering
WilmerHale has advised Xilio Therapeutics on the offering, and Cooley has advised the underwriter. Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company, announced the pricing...
Solid Biosciences’ $200 Million Common Stock Offering
Wilmer Cutler Pickering Hale and Dorr represented Solid Biosciences in the offering, and Davis Polk & Wardwell represented the underwriters. Solid Biosciences Inc. (Nasdaq: SLDB) (“Solid”),...